The future applications of flow cytometry (FCM) are briefly discussed. Whereas the early
goals of its clinical applications were cancer diagnosis and classification, it has now become …

Leukemia is a group of hematologic malignancies characterized by the proliferation of
abnormal lymphoid or hematopoietic cells in the bone marrow and frequent involvement of …

The primary scientific discovery that led to the application of flow cytometry to clinical
diagnosis was the hybridoma methodology of Kohler and Milstein with the resultant surge in …

Clinical flow cytometry is a relatively new and rapidly growing medical technology.
According to estimates, there were less than 1000 instruments in operation globally prior to …

The prognosis of patients with cancer is largely determined by the specific histological
diagnosis, tumor mass stage, and host performance status. The management of neoplastic …

In the last 40 years, flow cytometry has evolved from a cumbersome but promising
technology to a routine and indispensable diagnostic tool, descended but different from the …

Flow cytometry (FCM) combines the quantitative aspects of spectrophotometry with the
single cell resolution of microscopy and the speed of a microprocessor controlled flow …

Flow cytometric analysis has become an accepted medical practice in the diagnosis and
characterization of hematologic neoplasia, and its role in the management of patients with …

Flow cytometry: an overview Page 1 SPECIAL FEATURE Flow cytometry: an overview By
Danielle King Flow cytometry is the measurement and characterization of light-absorbing and …

The application of flow cytometry to hematology is emerging as an important new technique
in experimental and clinical leukemic research. In addition to the described methods to …